Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bhuwanatala Indah Permai Tbk. (BIPP) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Bhuwanatala Indah Permai Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Bhuwanatala Indah Permai Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Bhuwanatala Indah Permai Tbk. trades at Rp70 (market cap 316.81B, 265.26M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 1.44M 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap, and Bhuwanatala Indah Permai Tbk. is more actively traded (265.26M versus 1.44M). Which is the better fit depends on your goals.

BIPPLABS
Market Cap
316.81B584.6B
Volume
265.26M1.44M
Lot
2.65M14.4K
Turnover
19.02B209.72M
Average Price
71.72145.64
Value
19.02B209.72M
Indicative Equilibrium Price
70146
Indicative Equilibrium Volume
20.2K753

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BIPP
View details
LABS
View details

About Bhuwanatala Indah Permai Tbk.

PT Bhuwanatala Indah Permai Tbk (the Company) was initially established within the framework of Domestic Capital Investment Law No. 6 year 1968 as amended by law No. 12 year 1970 based on Notarial Deed No. 165 dated December 21, 1981 of Public Notary Koswara, S.H. PT Bhuwanatala operates in hotel management, retail properties, and office space. The company listed its shares on Over-The Counter Market, and since the merger of the OTC Market with the Surabaya Stock Exchange, the shares automatically listed on the SSX.

Read more on BIPP

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS